Replies to post #405384 on NorthWest Biotherapeutics Inc (NWBO)

[vator]

I will yield. Done for tonight.

[Poor Man -]

In addition to over $9 million in cap ex funded by NWBO, Advent has invoiced over $7.5 million to NWBO. Look under related party transactions in the 10K. When all’s said and done, NWBO will likely have funded over $20 million in working capital and cap ex before full scale production begins.

The following table summarizes expenses incurred to related parties (i.e., amounts invoiced) during the year ended December 31, 2020 and 2019 (amount in thousands) (some of which were for previous periods’ services and remain unpaid as noted in the second table below): For the year ended December 31, 2020 Advent BioServices $7,543

During the years ended December 31, 2020 and 2019, the Company capitalized $3.6 million and $0.9 million costs related to Sawston buildout in addition or the year ended

[sentiment_stocks]

How much of that equity carried over from when Advent was affiliated with Cognate?

How much money has LP herself put into or loaned to Advent?

How much of their initial equity was accrued by other vendors?